-
Pacific Biosciences of California, Inc. v. Oxford Nanopore Technologies, Inc. DC CAFC
- 1:17-cv-01353
- D. Del.
- Judge: Leonard P. Stark
- Filed: 09/25/2017
- Closed: 08/13/2020
- Latest Docket Entry: 09/08/2022
- PACER
1
Plaintiff
1
Defendant
7
Accused
Products
3
Patents-in-Suit
1,054
Days in
Litigation
-
Pacific Biosciences of California, Inc. v. Oxford Nanopore Technologies, Inc. DC CAFC
- 1:17-cv-01353
- D. Del.
- Judge: Leonard P. Stark
- Filed: 09/25/2017
- Closed: 08/13/2020
- Latest Docket Entry: 09/08/2022
- PACER
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
Claim # | Claim Text | Outcome |
---|---|---|
1 |
A method for sequencing a nucleic acid template comprising: providing a substrate having an upper solution above the substrate and a lower solution below the substrate, the substrate comprising a nanopore connecting the upper solution and lower
view more
|
Invalid
Entry 518 Entry 484 Entry 510 |
2 |
The method of claim 1 wherein the translocating enzyme comprises a polymerase, an exonuclease, or a helicase.
|
Invalid
Entry 518 Entry 510 |
12 |
The method of claim 1 wherein the substrate comprises an array of nanopores.
|
Invalid
Entry 518 Entry 510 |
Claim # | Claim Text | Outcome |
---|---|---|
1 |
A method of determining a nucleotide sequence of a region of interest in a polynucleotide, the method comprising: introducing a polynucleotide comprising a region of interest to a sequence analysis system comprising a nanopore in a membrane, wherein
view more
|
Invalid
Entry 518 Entry 484 Entry 510 |
2 |
The method of claim 1, wherein the nanopore comprises a protein channel.
|
Invalid
Entry 518 Entry 484 Entry 510 |
10 |
The method of claim 8, wherein the complementary strands are linked by a linker comprising a nucleotide.
|
Invalid
Entry 518 Entry 484 Entry 510 |
All Claims |
NA
|
Valid
Entry 484 |
Claim # | Claim Text | Outcome |
---|---|---|
1 |
A method for sequencing template nucleic acids comprising: a) providing a device comprising an array of nanopores a in contact with a solution, the solution comprising a plurality of template nucleic acids above the nanopore; b) providing a voltage
view more
|
Invalid
Entry 518 Entry 510 |
4 |
The method of claim 1 wherein the at least N monomeric units comprise 5-mers.
|
Invalid
Entry 518 Entry 510 |
18 |
The method of claim 1 wherein the device substrate comprises a semiconductor chip comprising an array of nanopores.
|
Invalid
Entry 518 Entry 510 |
All Claims |
NA
|
Valid
Entry 484 |
-
Infringement
Oxford Nanopore Technologies Limited
- 3 Details
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Flongle sequencing systemsGridION X5 sequencing systemsMinION sequencing systemsPromethION sequencing systemsreagents and kits used to generate 1D squared readsreagents and kits used to generate 2D readsSmidgION | US 9,678,056 B2 |
1, 2, 12
|
Infringement
Entry 518Entry 484 Entry 510 |
Flongle sequencing systemsGridION X5 sequencing systemsMinION sequencing systemsPromethION sequencing systemsreagents and kits used to generate 1D squared readsreagents and kits used to generate 2D readsSmidgION | US 9,738,929 B2 |
1, 2, 10
|
No infringement
Entry 518Entry 484 Entry 510 |
Flongle sequencing systemsGridION X5 sequencing systemsMinION sequencing systemsPromethION sequencing systemsreagents and kits used to generate 1D squared readsreagents and kits used to generate 2D readsSmidgION | US 9,772,323 B2 |
1, 4, 18
|
Infringement
Entry 518Entry 484 Entry 510 |